Notice of Ordering Period Extensionclinical Tender in USA - 145442743

Procurement Summary

Country: USA

Summary: Notice of Ordering Period Extensionclinical Evaluation of Phenserine Tartrate Extended Controlled Release Tablet

Deadline: 30 Jul 2026

Posting Date: 18 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 145442743

Document Ref. No.: 75N95024D00002

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

INTRODUCTION
PURSUANT TO RFO SUBPART 5.101- PRESOLICITATION NOTICE, THIS IS A NOTICE OF A PROPOSED CONTRACT ACTION.
THIS IS A NOTICE OF INTENT TO AWARD A MODIFICATION UNDER CONTRACT NO. 75N95024D00002 WITH THE UNIVERSITY OF EXETER, UNITED KINGDOM, TO EXTEND THE ORDERING PERIOD BY ONE (1) YEAR.
The National Institute on Aging (NIA) intends to modify the single-award Indefinite Quantity Indefinite Delivery (IDIQ) contract no. 75N95024D00002, Clinical evaluation of Phenserine tartrate Extended Controlled Release Tablet (ECRT) formulation in early mild Alzheimer-s disease and mild to moderate traumatic brain injury. This modification will extend the ordering period as denoted in IDIQ contract clause FAR 52.216-18, Ordering (AUG 2020), to be extended from August 1, 2026, to August 1, 2027.
The extension of the IDIQ ordering period will allow for work, especially initially planned task orders 2 and 3 of the IDIQ Statement of Work to be completed. There are no anticipated follow-on procurements at the writing of this Notice.
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The requirement is classified under NAICS code is 541990: All Other Professional, Scientific, and Technical Services, with a size standard of $19.5M.
REGULATORY AUTHORITY
The resultant modification will include all the applicable provisions and clauses of the RFO initiative, in accordance with Executive Order 14275 and OMB Memorandum M-25-26.
STATUTORY AUTHORITY
This modification is conducted under the authority of 41 U.S.C. 3304(a)(1) and in accordance with RFO Subpart 6.103-1- Only one responsible source and no other supplies or services will satisfy agency requirements.
DESCRIPTION
Background
There is a significant unmet need for Alzheimer-s disease therapeutics as well as drugs that favorably impact the consequences of brain injury as it can initiate cascades of biological events that may lead to long-term neurodegenerative disorders such as Alzh...
Notice ID: 75n95024d00002

Department/Ind. Agency: health and human services, department of

Sub-tier: national institutes of health

Office: national institutes of health nida

Product Service Code: b504 - special studies/analysis- chemical/biological

NAICS Code: 541990 - All Other Professional, Scientific, and Technical Services

Inactive Dates: aug 14, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice